On September 5, 2019 Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, reported that it will present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019 in New York City (Press release, Genprex, SEP 5, 2019, View Source [SID1234539317]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Genprex’s Chairman and Chief Executive Officer, Rodney Varner, will lead the company’s presentation and will be available for one-on-one meetings.
Genprex will present at the H.C. Wainwright 21st Annual Global Investment Conference as follows:
Date: Tuesday, September 10, 2019
Time: 3:00-3:25 p.m. EDT
Venue: Lotte New York Palace Hotel, New York City
Room: Holmes I (4th Floor)
Several networking opportunities are still available to investors or delegates of other companies that may wish to meet the Genprex team one-on-one. Those interested in setting a meeting are asked to contact the company at [email protected].